Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Methods of screening for agents that modulate the interaction of RGS and Gαq and urinary incontinence

Methods of screening for agents that modulate the interaction of RGS and Gαq and urinary incontinence

US Patent 7846671 · Granted Dec 7, 2010

Estimated economic value: $49,606,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof2025
Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof2025
PCSK9 iRNA compositions and methods of use thereof2025
Extrahepatic delivery2025
Freeform text analysis and processing for neurostimulation data2025
Systems and methods for reducing neurostimulation electrode configuration and pa2025
Xanthine dehydrogenase (XDH) iRNA compositions and methods of use thereof2024
Extrahepatic delivery2024
Complement component C5 iRNA compositions and methods of use thereof2024
Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof2024
Glucokinase (GCK) iRNA compositions and methods of use thereof2024
Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof2023